Skip to main content

Table 2 Laboratory findings of patients infected with COVID-19 on admission to hospital

From: Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak

 

Total

(n = 156)

Survivor

(n = 100)

Non-survivor

(n = 56)

P valuea

WBC count, 109/L

6.2 (4.7–8.3)

5.6 (4.5–7.2)

7.8 (5.5–12.6)

< 0.001

Neutrophil count, 109/L

4.0 (3.0–6.8)

3.4 (2.5–5.0)

6.8 (4.5–11.3)

< 0.001

Lymphocyte count, 109/L

1.2 (0.7–1.7)

1.4 (1.0–1.9)

0.7 (0.5–1.1)

0.503

NEU (%), %

71.0 (58.9–84.4)

62.9 (55.3–72.4)

86.7 (76.3–91.0)

< 0.001

LYM (%), %

19.7 (10.5–30.6)

27.6 (18.4–33.5)

8.7 (4.7–14.3)

< 0.001

Hemoglobin, g/L

123.7 (114.2–136.6)

125.0 (115.5–136.3)

122.4 (113.9–135.8)

0.246

Platelet, 109/L

194.0 (157.0–249.0)

218.5 (172.3–259.5)

168.0 (114.0–200.0)

< 0.001

Total bilirubin, mmol/L

10.9 (7.5–17.2)

10.7 (7.5–14.6)

13.0 (7.5–25.6)

0.057

LDH, U/L

197.0 (159.5–279.0)

175.0 (149.0–219.0)

310.5 (201.0–479.3)

< 0.001

ALT, U/L

20.2 (13.5–39.5)

19.5 (13.0–37.9)

22.1 (14.7–41.5)

0.400

AST, U/L

21.7 (16.1–34.2)

18.8 (15.1–26.6)

30.0 (21.3–55.3)

0.002

Albumin, g/L

37.5 (33.8–42.6)

39.9 (36.5–43.3)

33.1 (29.7–33.6)

< 0.001

Globulin, g/L

28.7 (24.4–32.9)

28.2 (24.1–30.9)

31.5 (24.8–34.9)

0.014

BUN, mmol/L

4.7 (3.7–6.2)

4.2 (3.3–5.3)

6.2 (5.0–10.8)

< 0.001

Creatinine, μmol/L

66.1 (50.3–84.2)

64.8 (50.9–75.1)

74.2 (47.0–126.9)

0.008

CK, U/L

68.0 (45.0–121.0)

63.0 (40.0–96.0)

112.8 (62.3–245.0)

0.028

CK-MB, U/L

1.6 (0.8–4.6)

0.9 (0.7–1.4)

4.3 (1.7–13.3)

0.044

troponin I, pg/ml

20.0 (4.1–57.5)

10.0 (3.0–20.0)

50.0 (22.3–115.0)

0.013

BNP, ng/L

118.5 (32.5–392.7)

56.8 (20.0–132.9)

374.7 (135.1–814.5)

0.069

D-dimer, mg/L

1.0 (0.4–4.6)

0.7 (0.2–1.6)

3.3 (1.2–7.8)

0.025

CRP, mg/L

0.9 (0.1–3.6)

0.2 (0.1–1.6)

4.1 (2.5–7.2)

< 0.001

Procalcitonin, ng/mL

0.06 (0.04–0.14)

0.05 (0.04–0.06)

0.37 (0.12–0.77)

0.022

IL-6, pg/mL

7.1 (2.4–24.7)

2.9 (1.5–7.4)

79.6 (9.6–212.5)

0.027

CD19+, count/μL

12.6 (9.0–18.9)

11.1 (8.6–17.0)

16.6 (10.1–19.1)

0.292

CD3+, count/μL

68.9 (57.4–75.3)

70.6 (62.0–76.7)

66.8 (54.6–71.4)

0.329

CD4+, count/μL

38.8 (34.6–46.0)

38.8 (31.4–45.2)

39.4 (36.2–52.5)

0.183

CD8+, count/μL

25.3 (19.2–32.3)

26.7 (19.6–33.9)

20.5 (13.9–30.5)

0.063

CD4/CD8

1.6 (1.1–2.3)

1.5 (1.0–2.1)

1.8 (1.2–3.9)

0.071

  1. Notes: Data presented as n (%) or median (IQR)
  2. Abbreviations: COVID-19 Coronavirus Disease 2019, WBC White blood cell, NEU (%) Percentage of neutrophils, LYM (%) Percentage of lymphocytes, LDH Lactate dehydrogenase, ALT Alanine aminotransferase, AST Aspartate aminotransferase, BUN Blood urea nitrogen, CK Creatine kinase-MB, CK-MB Creatine kinase-MB, BNP Brain natriuretic peptide, CRP C-reactive protein, IL-6,Interleukin-6
  3. aP values indicate differences between survivors and non-survivors. P < 0.05 was considered statistically significant
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us